Literature DB >> 16848429

Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents.

Valérie C Pierre1, Mauro Botta, Silvio Aime, Kenneth N Raymond.   

Abstract

The self-assembly of supramolcular clusters of Gd(III) hydroxypyridinone complexes, templated by an Fe(III) terephthalamide center, is presented. The peripheral Gd(III) ions are each coordinated by two water molecules which exchange rapidly with the bulk solvent. These properties, along with the high rigidity of the supramolecules, efficiently increase the rotational correlation times of the cluster, resulting in high relaxivities at high magnetic fields and hence making these complexes good candidates for MRI contrast agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848429      PMCID: PMC3190973          DOI: 10.1021/ja061323j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

1.  Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

2.  High relaxivity confined to a small molecular space: a metallostar-based, potential MRI contrast agent.

Authors:  João Bruno Livramento; Eva Tóth; Angélique Sour; Alain Borel; André E Merbach; Robert Ruloff
Journal:  Angew Chem Int Ed Engl       Date:  2005-02-25       Impact factor: 15.336

Review 3.  Next generation, high relaxivity gadolinium MRI agents.

Authors:  Kenneth N Raymond; Valérie C Pierre
Journal:  Bioconjug Chem       Date:  2005 Jan-Feb       Impact factor: 4.774

4.  Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion.

Authors:  Jakub Rudovsky; Petr Hermann; Mauro Botta; Silvio Aime; Ivan Lukes
Journal:  Chem Commun (Camb)       Date:  2005-03-18       Impact factor: 6.222

5.  Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.

Authors:  S M Cohen; J Xu; E Radkov; K N Raymond; M Botta; A Barge; S Aime
Journal:  Inorg Chem       Date:  2000-12-11       Impact factor: 5.165

6.  Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.

Authors:  David A Fulton; Mark O'Halloran; David Parker; Kanthi Senanayake; Mauro Botta; Silvio Aime
Journal:  Chem Commun (Camb)       Date:  2004-12-17       Impact factor: 6.222

7.  The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes.

Authors:  Ann J. Stemmler; Jeff W. Kampf; Martin L. Kirk; Bassel H. Atasi; Vincent L. Pecoraro
Journal:  Inorg Chem       Date:  1999-06-14       Impact factor: 5.165

8.  A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions.

Authors:  João Bruno Livramento; Angélique Sour; Alain Borel; André E Merbach; Eva Tóth
Journal:  Chemistry       Date:  2006-01-23       Impact factor: 5.236

9.  The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent.

Authors:  Gaëlle M Nicolle; Eva Tóth; Heribert Schmitt-Willich; Bernd Radüchel; André E Merbach
Journal:  Chemistry       Date:  2002-03-01       Impact factor: 5.236

10.  Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.

Authors:  Dan M J Doble; Marco Melchior; Brendon O'Sullivan; Carsten Siering; Jide Xu; Valérie C Pierre; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2003-08-11       Impact factor: 5.165

View more
  9 in total

1.  Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.

Authors:  F Guérard; M Beyler; Y-S Lee; R Tripier; J-F Gestin; M W Brechbiel
Journal:  Dalton Trans       Date:  2017-04-05       Impact factor: 4.390

2.  Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-10-02       Impact factor: 5.165

3.  Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

Authors:  Joel Garcia; Jaladhar Neelavalli; E Mark Haacke; Matthew J Allen
Journal:  Chem Commun (Camb)       Date:  2011-11-02       Impact factor: 6.222

4.  Metal-Organic Polyhedron with Four Fe(III) Centers Producing Enhanced T1 Magnetic Resonance Imaging Contrast in Tumors.

Authors:  Gregory E Sokolow; Matthew R Crawley; Daniel R Morphet; Didar Asik; Joseph A Spernyak; A J Robert McGray; Timothy R Cook; Janet R Morrow
Journal:  Inorg Chem       Date:  2022-01-24       Impact factor: 5.436

Review 5.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

6.  Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

Authors:  Joshua Bryson; Jeffrey W Reineke; Theresa M Reineke
Journal:  Macromolecules       Date:  2012-11-13       Impact factor: 5.985

7.  Use of YbIII-centered near-infrared (NIR) luminescence to determine the hydration state of a 3,2-HOPO-based MRI contrast agent.

Authors:  Evan G Moore; Michael Seitz; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2008-08-26       Impact factor: 5.165

Review 8.  Could magnetic resonance provide in vivo histology?

Authors:  Marco Dominietto; Markus Rudin
Journal:  Front Genet       Date:  2014-01-13       Impact factor: 4.599

9.  T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents.

Authors:  Jingjing Li; Jia You; Chen Wu; Yue Dai; Meilin Shi; Lina Dong; Kai Xu
Journal:  Int J Nanomedicine       Date:  2018-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.